Jane Street’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
198,657
+97,923
| +97% | +$1.1M | ﹤0.01% | 2037 |
|
|
2025
Q1 | $460K | Sell |
100,734
-55,494
| -36% | -$254K | ﹤0.01% | 4045 |
|
|
2024
Q4 | $881K | Sell |
156,228
-60,673
| -28% | -$342K | ﹤0.01% | 3124 |
|
|
2024
Q3 | $1.05M | Sell |
216,901
-36,899
| -15% | -$179K | ﹤0.01% | 3327 |
|
|
2024
Q2 | $1.24M | Buy |
253,800
+226,657
| +835% | +$1.11M | ﹤0.01% | 3381 |
|
|
2024
Q1 | $360K | Sell |
27,143
-245,083
| -90% | -$3.25M | ﹤0.01% | 4431 |
|
|
2023
Q4 | $3.79M | Buy |
272,226
+252,441
| +1,276% | +$3.52M | ﹤0.01% | 1769 |
|
|
2023
Q3 | $262K | Sell |
19,785
-65,139
| -77% | -$864K | ﹤0.01% | 4186 |
|
|
2023
Q2 | $1.59M | Sell |
84,924
-69,666
| -45% | -$1.31M | ﹤0.01% | 2624 |
|
|
2023
Q1 | $2.23M | Buy |
154,590
+140,774
| +1,019% | +$2.03M | ﹤0.01% | 1915 |
|
|
2022
Q4 | $267K | Buy |
+13,816
| New | +$267K | ﹤0.01% | 4090 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6394 |
|
|
2022
Q2 | – | Sell |
-12,333
| Closed | -$281K | – | 6320 |
|
|
2022
Q1 | $281K | Sell |
12,333
-35,804
| -74% | -$816K | ﹤0.01% | 4374 |
|
|
2021
Q4 | $1.78M | Buy |
+48,137
| New | +$1.78M | ﹤0.01% | 2052 |
|
|
2021
Q3 | – | Sell |
-9,492
| Closed | -$572K | – | 5946 |
|
|
2021
Q2 | $572K | Buy |
+9,492
| New | +$572K | ﹤0.01% | 3274 |
|